CareDx (CDNA) Reports In-Line Q3 EPS

CareDx (NASDAQ: CDNA) reported Q3 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $53.4 million versus the consensus estimate of $53.01 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Byline Bancorp (BY) Tops Q1 EPS by 6c
• Data I/o Corp (DAIO) Misses Q2 EPS by 7c